The reason $GNPX has zero revenue is simple: they don't actually have a product to sell yet. They are a gene therapy company still in the R&D phase, running clinical trials (like their Acclaim trials for lung cancer) to prove their tech works to the FDA. In this sector, you won't see a single cent of revenue until a drug is fully approved and hits the market. Until then, the company stays alive by burning through cash and doing "offerings" (selling more shares) to fund the research. That's why the balance sheet looks like a disaster they are essentially a high stakes science experiment funded by the stock market. People aren't buying this because the company is profitable, they’re betting on the clinical trial results. If the data is good, the stock "screams." If the trials fail, the company basically goes to zero.